StreetInsider.com News Articles

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

VALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Thu, 18 Jun 2026 08:40:00 -0400

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients
Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow
RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand

ONERHT Foundation Raises Over S$280,000 for Local Charities and Announces New Leadership at 11th Anniversary Charity Golf & Gala Dinner

Thu, 04 Jun 2026 21:00:00 -0400

SINGAPORE, Jun 5, 2026 - (JCN Newswire) - - ONERHT Foundation Ltd ("Foundation"), the corporate social responsibility vehicle of RHTLaw Asia LLP and the RHT Group of Companies (collectively, "ONERHT") celebrated its 11th anniversary by hosting the annual Charity Golf & Gala Dinner at Sentosa Golf Club on 28 May 2026.

The event, graced by Guest of Honour Mr Masagos Zulkifli, Minister for Social and Family Development, drew over 120 golfers from Singapore's legal and professional community for a day of sports and philanthropy, culminating in a gala dinner that reaffirmed the Foundation's enduring commitment to make a difference in

ONERHT Foundation Raises Over S$280,000 for Local Charities and Announces New Leadership at 11th Anniversary Charity Golf & Gala Dinner

Thu, 04 Jun 2026 21:00:00 -0400

ONERHT Foundation Raises Over S$280,000 for Local Charities and Announces New Leadership at 11th Anniversary Charity Golf & Gala Dinner

Thu, 04 Jun 2026 21:00:00 -0400

ONERHT Foundation Raises Over S$280,000 for Local Charities and Announces New Leadership at 11th Anniversary Charity Golf & Gala Dinner

Thu, 04 Jun 2026 21:00:00 -0400

ONERHT Foundation Raises Over S$280,000 for Local Charities and Announces New Leadership at 11th Anniversary Charity Golf & Gala Dinner

Thu, 04 Jun 2026 21:00:00 -0400

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

VALENCIA, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President and Chief Executive Officer, and David O’Toole, Chief Financial Officer, on May 20, 2026, at 4:00 p.m. Pacific Time (May 21, 2026, at 9:00 a.m. Australian Eastern Standard Time).

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.

AVITA Medical to Host Investor Webinar Briefing

Sun, 17 May 2026 18:00:00 -0400

The webinar presentation will cover financial and business results from AVITA Medical’s recent first quarter 2026 earnings webcast and will conclude with a Q&A session.